$5.39B
Revenue
$-3.65B
Net Income
2.67%
Gross Margin
-66.55%
Op. Margin
$-3.94B
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Total Revenue | $5.39B | $5.39B | $4.97B | $4.43B | $1.66B | $55.00M |
| Revenue Growth % | 0.0% | 8.4% | 12.1% | 167.4% | 2914.5% | nan% |
| Cost of Revenue | $5.24B | $5.24B | $6.17B | $6.46B | $4.78B | $520.00M |
| Gross Profit | $144.00M | $144.00M | $-1.20B | $-2.03B | $-3.12B | $-465.00M |
| Gross Margin % | 2.7% | 2.7% | -24.1% | -45.8% | -188.4% | -845.5% |
| Operating Expenses | $3.73B | $3.73B | $3.49B | $3.71B | $3.73B | $3.75B |
| Research & Development | $1.67B | $1.67B | $1.61B | $2.00B | $1.94B | $1.85B |
| Selling General & Admin | $2.06B | $2.06B | $1.88B | $1.71B | $1.79B | $1.24B |
| Operating Income | $-3.58B | $-3.58B | $-4.69B | $-5.74B | $-6.86B | $-4.22B |
| Operating Margin % | -66.5% | -66.5% | -94.3% | -129.4% | -413.5% | -7672.7% |
| Interest Expense | $222.00M | $222.00M | $279.00M | $220.00M | $103.00M | $29.00M |
| Interest Income | $293.00M | $293.00M | $385.00M | $522.00M | $193.00M | $3.00M |
| Other Income/Expense | $-54.00M | $-54.00M | $-7.00M | $6.00M | $18.00M | $-1.00M |
| Income Before Tax | $-3.62B | $-3.62B | $-4.74B | $-5.43B | $-6.75B | $-4.69B |
| Income Tax Expense | $6.00M | $6.00M | $5.00M | $1.00M | $4.00M | - |
| Net Income | $-3.65B | $-3.65B | $-4.75B | $-5.43B | $-6.75B | $-4.69B |
| Net Margin % | -67.7% | -67.7% | -95.5% | -122.5% | -407.2% | -8523.6% |
| Basic EPS | -3.06 | -3.07 | -4.69 | -5.74 | -7.40 | -22.98 |
| Diluted EPS | -3.06 | -3.07 | -4.69 | -5.74 | -7.40 | -22.98 |
| Basic Shares Outstanding | - | 1.19B | 1.01B | 947.0M | 913.0M | 204.0M |
| Diluted Shares Outstanding | - | 1.19B | 1.01B | 947.0M | 913.0M | 204.0M |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.58B | $5.29B | $7.86B | $11.57B | $18.13B |
| Short-term Investments | $2.50B | $2.41B | $1.51B | - | - |
| Accounts Receivable | $555.00M | $443.00M | $161.00M | $102.00M | $26.00M |
| Inventory | $1.59B | $2.25B | $2.62B | $1.35B | $274.00M |
| Other Current Assets | $361.00M | $192.00M | $164.00M | $112.00M | $126.00M |
| Total Current Assets | $8.59B | $10.58B | $12.31B | $13.13B | $18.56B |
| Property Plant & Equipment | - | - | - | $3.76B | $3.18B |
| Other Non-current Assets | $582.00M | $446.00M | $235.00M | $658.00M | $324.00M |
| Total Assets | $14.86B | $15.41B | $16.78B | $17.88B | $22.29B |
| Accounts Payable | $595.00M | $499.00M | $981.00M | $1.00B | $483.00M |
| Accrued Liabilities | $1.44B | $835.00M | $1.15B | $1.15B | $667.00M |
| Deferred Revenue | $1.28B | $552.00M | - | - | $74.00M |
| Other Current Liabilities | $96.00M | $121.00M | - | - | - |
| Total Current Liabilities | $3.69B | $2.25B | $2.49B | $2.42B | $1.31B |
| Long-term Debt | $4.44B | $4.44B | $4.43B | $1.23B | $1.23B |
| Other Non-current Liabilities | $1.59B | $1.78B | $395.00M | $111.00M | $23.00M |
| Total Liabilities | $10.27B | $8.85B | $7.64B | $4.08B | $2.78B |
| Common Stock | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M |
| Retained Earnings | $-26.95B | $-23.30B | $-18.56B | $-13.13B | $-6.37B |
| Total Stockholders Equity | $4.59B | $6.56B | $9.14B | $13.80B | $19.51B |
| Total Liabilities & Equity | $14.86B | $15.41B | $16.78B | $17.88B | $22.29B |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Net Income | $-3.65B | $-3.65B | $-4.75B | $-5.43B | $-6.75B | $-4.69B |
| Depreciation & Amortization | $1.38B | $784.00M | $1.03B | $937.00M | $652.00M | $197.00M |
| Stock-based Compensation | $1.31B | $741.00M | $692.00M | $821.00M | $987.00M | $570.00M |
| Change in Receivables | $-108.00M | $112.00M | $282.00M | $59.00M | $76.00M | $20.00M |
| Change in Inventory | $-266.00M | $-522.00M | $-307.00M | $1.60B | $1.66B | $369.00M |
| Operating Cash Flow | $-1.09B | $-779.00M | $-1.72B | $-4.87B | $-5.05B | $-2.62B |
| Capital Expenditure | $2.85B | $1.71B | $1.14B | $1.03B | $1.37B | $1.79B |
| Investing Cash Flow | $-3.35B | $-1.83B | $-1.98B | $-2.51B | $-1.37B | $-1.79B |
| Stock Issued | $1.50B | $750.00M | $64.00M | $61.00M | $102.00M | $2.66B |
| Financing Cash Flow | $1.63B | $886.00M | $1.14B | $3.13B | $99.00M | $19.83B |
| Net Change in Cash | $-2.80B | $-1.72B | $-2.56B | $-4.24B | $-6.32B | $15.41B |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $1.56B | - | $4.10B | - |
| Cost of Revenue | $1.53B | - | $4.08B | - |
| Gross Profit | $24.00M | - | $24.00M | - |
| Operating Expenses | $1.01B | - | $2.78B | - |
| Research & Development | $453.00M | - | $1.24B | - |
| Selling General & Admin | $554.00M | - | $1.53B | - |
| Operating Income | $-983.00M | - | $-2.75B | - |
| Interest Expense | $69.00M | - | $210.00M | - |
| Interest Income | $76.00M | - | $229.00M | - |
| Other Income/Expense | $-191.00M | - | $-86.00M | - |
| Income Before Tax | $-1.17B | - | $-2.82B | - |
| Income Tax Expense | $-1.00M | - | $3.00M | - |
| Net Income | $-1.17B | $-1.46B | $-2.83B | - |
| Basic EPS | -0.96 | - | -2.42 | - |
| Diluted EPS | -0.96 | - | -2.42 | - |
| Basic Shares Outstanding | $1.22B | - | $1.17B | - |
| Diluted Shares Outstanding | $1.22B | - | $1.17B | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $4.44B | $5.29B |
| Short-term Investments | $2.65B | $2.41B |
| Accounts Receivable | $203.00M | $443.00M |
| Inventory | $1.64B | $2.25B |
| Other Current Assets | $346.00M | $192.00M |
| Total Current Assets | $9.28B | $10.58B |
| Other Non-current Assets | $553.00M | $446.00M |
| Total Assets | $15.22B | $15.41B |
| Accounts Payable | $554.00M | $499.00M |
| Accrued Liabilities | $1.39B | $835.00M |
| Total Current Liabilities | $3.42B | $2.25B |
| Long-term Debt | $4.44B | $4.44B |
| Other Non-current Liabilities | $1.74B | $1.78B |
| Total Liabilities | $10.13B | $8.85B |
| Common Stock | $1.00M | $1.00M |
| Retained Earnings | $-26.14B | $-23.30B |
| Total Stockholders Equity | $5.08B | $6.56B |
| Total Liabilities & Equity | $15.22B | $15.41B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-1.17B | $-1.46B | $-2.83B | - |
| Depreciation & Amortization | - | - | $583.00M | - |
| Stock-based Compensation | - | - | $551.00M | - |
| Change in Receivables | - | - | $-267.00M | - |
| Change in Inventory | - | - | $-511.00M | - |
| Operating Cash Flow | - | - | $-98.00M | - |
| Capital Expenditure | - | - | $1.25B | - |
| Investing Cash Flow | - | - | $-1.51B | - |
| Stock Issued | - | - | $750.00M | - |
| Financing Cash Flow | - | - | $747.00M | - |
| Net Change in Cash | - | - | $-853.00M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.